Skip to main content
Clinical Trials/DRKS00025048
DRKS00025048Recruiting未知

ower respiratory tract Microbiome in patients with Lung cancer (LML)

niversitätsklinikum FreiburgKlinik für Thoraxchirurgie0 sites150 target enrollmentStarted: October 13, 2021Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
150

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Non-randomized controlled study
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • 1. Patients with a) suspected or proven lung cancer (study group) or b) COPD (control
  • 2. scheduled for bronchoscopy and/or surgical resection at the Medical Center Freiburg
  • 3. Male and female patients, = 18 years of age

Exclusion Criteria

  • 1. Patients with history of systemic corticosteroids and/or immunosuppressive therapy in the last 12 months before enrolment
  • 2. Patients with history of systemic antibiotics for any reason in the last 4 weeks before enrolment
  • 3. Patients with history of chemotherapy and/or radiation

Investigators

Sponsor
niversitätsklinikum FreiburgKlinik für Thoraxchirurgie

Similar Trials